Pay in 4 interest-free payments of $6.98 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
In the SURMOUNT-1 trial, tirzepatide users saw a 10.9% lean mass reduction over 72 weeks, while approximately 74% of total body weight lost came from fat mass
Diabetic retinopathy: This eye problem typically occurs in people with diabetes Possible increased risk of thyroid cancer: Seen in animal studies, it is not known if Wegovy can cause thyroid cancer in people
Week 3 of semaglutide, 3 lbs 4 ounces down
These science-based strategies can help maintain progress and confidence
Storage:Store refrigerated at 28C under controlled laboratory conditions
Published online October 10, 2024:1-4
US$ 21.97
US$ 29.50
US$ 28.35
US$ 25.93
US$ 29.53
US$ 27.62
US$ 25.27
